PSNL: Personalis, Inc. Stock

by  •  • Comments Off on PSNL: Personalis, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 69.65
Enterprise Value ($M) 15.54
Book Value ($M) 129.44
Book Value / Share 2.53
Price / Book 0.54
NCAV ($M) 51.09
NCAV / Share 1.00
Price / NCAV 1.36

Profitability (mra)
Return on Invested Capital (ROIC) -0.61
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.56

Liquidity (mrq)
Quick Ratio 2.99
Current Ratio 3.11

Balance Sheet (mrq) ($M)
Current Assets 146.74
Assets 225.10
Liabilities 95.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 73.48
Operating Income -96.29
Net Income -108.30
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -56.26
Cash from Investing 13.10
Cash from Financing 11.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-29 13G/A ARK Investment Management LLC 13.61 21.29
01-26 13G/A BlackRock Inc. 6.80 -6.85
12-07 13G/A Jpmorgan Chase & Co 0.00 -100.00
12-05 13G Tempus Labs, Inc. 15.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-30 59,263 289,678 20.46
2024-04-29 23,263 15,717 148.01
2024-04-26 10,803 7,102 152.11

(click for more detail)

Similar Companies
CNTG – Centogene N.V. CSTL – Castle Biosciences, Inc.
FLGT – Fulgent Genetics, Inc. RDNT – RadNet, Inc.
SERA – Sera Prognostics, Inc.


Financial data and stock pages provided by
Fintel.io